Piramal Pharma Solutions (PPS) has been recognised as the ‘Industry Partner of the Year’ at the recently held Global Generics & Biosimilars Awards 2017, in Frankfurt, Germany.
Takeda will jumpstart the new company’s discovery efforts by providing a 12-person cardiovascular research team from its Shonan, Japan site, including fully equipped laboratory space
Firms combine ambr® technology with the BioProfile® FLEX2;Unique tool will allow massive quantities of cell culture data to be collected during upstream processing QbD studies.
MilliporeSigma said that its CHOZN expression system will be used by SystImmune, a Seattle-based biotechnology company, for commercial development of a bi-specific antibody therapeutic.